Cubed Biotech Inc. is a Montréal-based Canadian psychedelic  biotechnology firm federally licensed from Health Canada to develop, manufacture, and commercialize psychedelic medicine to advance the current treatments of mental illness and addiction. We cultivate, extract, and purify natural entheogens including psilocybin from mushrooms, mescaline from cacti, and ayahuasca’s DMT and monoamine oxidase inhibitors all with synthetic options. Our 18,700 square feet Montreal facility is the preeminent psychedelic factory in the world as told to us by a Nasdaq CEO. Cubed’s drug development is focused on reverse engineering natural medicines with safe historical usage to produce finished drug products for Cubed and pharmaceutical companies.

View more details about Cubed Biotech Inc here.

Note: This form submits an investment inquiry to Cubed Biotech Inc, and does not constitute an official investment.